PULMONX CORPORATION Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
PULMONX CORPORATION (LUNG) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $40.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $40.00K, a 91.84% decline year-over-year.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $120.00K, a 80.23% decline year-over-year.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $925.00K, a 94.56% decline from fiscal 2024.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $17.02M, a 5891.55% increase from fiscal 2023.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $284.00K, a 24.02% increase from fiscal 2022.
- PULMONX CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $229.00K, a 84.32% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $40.00K 10-Q · filed 2026-08-04 | $160.00K derived: sum of 3 quarters · filed 2026-08-04 | $160.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $40.00K 10-Q · filed 2026-05-04 | $160.00K derived: sum of 2 quarters · filed 2026-05-04 | $160.00K derived: sum of 3 quarters · filed 2026-05-04 | $475.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $120.00K derived: sum of 2 quarters · filed 2026-03-10 | $435.00K derived: sum of 3 quarters · filed 2026-08-04 | $925.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $315.00K derived: sum of 2 quarters · filed 2026-08-04 | $805.00K 10-Q · filed 2025-11-12 | $1.41M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $805.00K 10-Q · filed 2026-08-04 | $1.41M derived: sum of 3 quarters · filed 2026-08-04 | $1.46M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $490.00K 10-Q · filed 2026-05-04 | $1.10M derived: sum of 2 quarters · filed 2026-05-04 | $1.15M derived: sum of 3 quarters · filed 2026-05-04 | $17.51M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $607.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $656.00K derived: sum of 2 quarters · filed 2026-03-10 | $17.02M derived: sum of 3 quarters · filed 2026-03-10 | $17.02M 10-K · filed 2026-03-10 |
| 2024-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $16.41M derived: sum of 2 quarters · filed 2025-11-12 | $16.41M 10-Q · filed 2025-11-12 | $16.44M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $16.36M 10-Q · filed 2025-08-01 | $16.39M derived: sum of 3 quarters · filed 2025-08-01 | $16.42M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-02 | $32.00K derived: sum of 2 quarters · filed 2025-05-02 | $60.00K derived: sum of 3 quarters · filed 2025-05-02 | $284.00K derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $60.00K derived: sum of 2 quarters · filed 2025-02-25 | $284.00K derived: sum of 3 quarters · filed 2025-02-25 | $284.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $252.00K derived: sum of 2 quarters · filed 2024-11-01 | $252.00K 10-Q · filed 2024-11-01 | $290.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $224.00K 10-Q · filed 2024-08-02 | $262.00K derived: sum of 3 quarters · filed 2024-08-02 | $315.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-03 | $38.00K derived: sum of 2 quarters · filed 2024-05-03 | $91.00K derived: sum of 3 quarters · filed 2024-05-03 | $173.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $91.00K derived: sum of 2 quarters · filed 2024-02-27 | $173.00K derived: sum of 3 quarters · filed 2024-02-27 | $229.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $135.00K derived: sum of 2 quarters · filed 2023-11-03 | $191.00K 10-Q · filed 2023-11-03 | $386.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $138.00K 10-Q · filed 2023-08-04 | $333.00K derived: sum of 3 quarters · filed 2023-08-04 | $1.60M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $56.00K 10-Q · filed 2023-05-08 | $251.00K derived: sum of 2 quarters · filed 2023-05-08 | $1.52M derived: sum of 3 quarters · filed 2023-05-08 | $1.52M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.46M derived: sum of 2 quarters · filed 2023-03-01 | $1.46M derived: sum of 3 quarters · filed 2023-03-01 | $1.46M 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.26M derived: sum of 2 quarters · filed 2022-11-08 | $1.26M 10-Q · filed 2022-11-08 | $1.32M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $53.00K derived: sum of 3 quarters · filed 2022-08-08 | $3.20M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $53.00K derived: sum of 2 quarters · filed 2022-05-09 | $3.20M derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.20M derived: sum of 2 quarters · filed 2022-03-01 | $3.94M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.88M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $735.00K 10-Q · filed 2021-08-10 | |||
| 2019-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $6.22M 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |